Glassman Wealth Services’s Fate Therapeutics FATE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q4
Sell
-53
Closed -$112 2010
2023
Q3
$112 Buy
+53
New +$112 ﹤0.01% 1961
2023
Q1
Sell
-76
Closed -$767 1926
2022
Q4
$767 Buy
76
+71
+1,420% +$717 ﹤0.01% 1505
2022
Q3
$0 Sell
5
-7
-58% ﹤0.01% 1757
2022
Q2
$0 Buy
+12
New ﹤0.01% 1770
2021
Q4
Sell
-33
Closed -$2K 1713
2021
Q3
$2K Buy
33
+30
+1,000% +$1.82K ﹤0.01% 1162
2021
Q2
$0 Buy
3
+2
+200% ﹤0.01% 1510
2021
Q1
$0 Buy
+1
New ﹤0.01% 1466
2019
Q3
Sell
-11
Closed 1137
2019
Q2
$0 Buy
+11
New ﹤0.01% 1160